SQZ Biotechnologies Co
SQZDelisted Jul 19, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604477
SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 31
- Q2 2023, 0 vs. previous quarter
- 13F value
- $2.96M
- Reported value at the end of Q2 2023
- Superinvestors holding
- 1
- At the end of Q2 2023
Superinvestors holding SQZ, Q2 2023
1 superinvestor reports holding SQZ Biotechnologies Co on Form 13F. Percentages are the stock's share of each portfolio.
Maverick Capital
Lee Ainslie
<0.1%
SQZ Biotechnologies Co's share of the portfolio
- Shares
- 1,050,286
- Value
- $283.6K
Latest insider trades
Open-market purchases and sales by SQZ Biotechnologies Co insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 (view filing) | Aug 15 | 1 day | Capasso RichardSee Remarks | SSale | −1.18K | $3.33 | −$3.94K | −100.0%0 after | |
| May 27, 2022 (view filing) | May 25 | 2 days | Jensen Klavs F.Director | PPurchase | +14.3K | $3.52 | +$50.4K | +4.2%353.3K after | |
| Dec 15, 2021 (view filing) | Dec 13 | 2 days | Schulman Amy WDirector, 10% Owner | PPurchase | +3.70K | $10.91 | +$40.4K | New position1.85K after | 2 lots |
Top 10 13F holders, Q2 2023
The largest institutional positions in SQZ Biotechnologies Co at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Temasek Holdings (Private) Ltd | 2,758,169 | $744.7K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 2,517,173 | $679.6K | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 1,606,309 | $434.0K | 0.01% | 00.0% | Unchanged |
| Maverick Capital LtdSuperinvestorMaverick Capital | 1,050,286 | $283.6K | 0.01% | −1,485−0.1% | Reduced |
| Vanguard Group Inc | 941,086 | $254.1K | 0.00% | −666−0.1% | Reduced |
| Stifel Financial Corp | 851,520 | $229.9K | 0.00% | −22,806−2.6% | Reduced |
| Laurion Capital Management LP | 412,865 | $111.5K | 0.00% | −18,535−4.3% | Reduced |
| Geode Capital Management, LLC | 135,360 | $36.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 83,603 | $23.0K | 0.00% | +9,300+12.5% | Added |
| Millennium Management LLC | 80,938 | $21.9K | 0.00% | −24,608−23.3% | Reduced |